WebLayperson summary date: April-2024 Page 1 of 16 Veeva number: M-XX-00004629 Summary of Clinical Trial Results A study to look at tominersen safety over 15 months in people with Huntington’s disease See the end of the summary for the full title of the study. About this summary This is a summary of the results of a clinical trial (called a WebJul 22, 2024 · Roche's (RHHBY) performance in first-half 2024 was impressive on strong demand for new medicines and COVID-19 test kits. Impact of biosimilars continues to hurt sales.
Roche introduces navify® Algorithm Suite, a digital library of …
WebMar 23, 2024 · Swiss pharma giant Roche announced Tuesday promising results from clinical trials of an anti-COVID cocktail developed with US biotech firm Regeneron. The results of the Phase 3 trial showed that ... WebAug 8, 2024 · Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the pivotal Phase III POLARIX trial investigating Polivy ® (polatuzumab vedotin) in combination with Rituxan ® (rituximab) plus cyclophosphamide, doxorubicin and prednisone (R-CHP) versus Rituxan plus cyclophosphamide, doxorubicin, … bauer deborah md
Raphael Roche, CFP®, CRPC™ - LinkedIn
WebAug 12, 2024 · In June 2024, Atea announced the achievement of a milestone associated with the development of AT-527, and in July 2024, received a $50 million payment under its license agreement with Roche. Under the license agreement, Roche and Atea are jointly developing AT-527 for the treatment of COVID-19. WebQ1 Results 2024 Virtual Media Conference. ... View more Events. Roche announced the company's 2024 first quarter results on Monday, 25 April 2024. Downloads. Media … WebDec 31, 2024 · ROCHE BOBOIS SA posted H1 2024 revenues of €159.6 million, a strong increase of 45.6% (49.1% at constant exchange rates) from €109.6 million in H1 2024. Brisk sales were recorded in all regions, particularly the United States and Europe. Revenues were 18.5% up before the covid crisis two years ago. bauer damasker